GAM Holding AG Has $5.96 Million Stock Holdings in Stryker Corporation (NYSE:SYK)

GAM Holding AG boosted its position in shares of Stryker Corporation (NYSE:SYK - Free Report) by 61.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 16,008 shares of the medical technology company's stock after buying an additional 6,108 shares during the quarter. GAM Holding AG's holdings in Stryker were worth $5,959,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Kohmann Bosshard Financial Services LLC acquired a new position in shares of Stryker in the 4th quarter valued at $25,000. Capital A Wealth Management LLC bought a new position in Stryker during the 4th quarter worth about $26,000. Rakuten Securities Inc. increased its holdings in Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares in the last quarter. Centricity Wealth Management LLC bought a new position in Stryker during the 4th quarter worth about $30,000. Finally, BankPlus Trust Department bought a new position in Stryker during the 4th quarter worth about $33,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Stryker Trading Up 0.6%

Shares of NYSE:SYK opened at $375.44 on Friday. Stryker Corporation has a 52-week low of $314.93 and a 52-week high of $406.19. The company has a market capitalization of $143.30 billion, a P/E ratio of 50.73, a price-to-earnings-growth ratio of 2.81 and a beta of 0.91. The company has a 50-day simple moving average of $374.95 and a 200 day simple moving average of $375.30. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64.

Stryker (NYSE:SYK - Get Free Report) last issued its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.73 by $0.11. The business had revenue of $5.87 billion during the quarter, compared to the consensus estimate of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. Stryker's revenue was up 11.9% on a year-over-year basis. During the same period last year, the business posted $2.50 EPS. Sell-side analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be given a dividend of $0.84 per share. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a yield of 0.89%. Stryker's dividend payout ratio (DPR) is presently 45.41%.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on the company. JMP Securities reiterated a "market perform" rating on shares of Stryker in a report on Monday, May 5th. Evercore ISI lowered their target price on Stryker from $400.00 to $390.00 and set an "outperform" rating for the company in a report on Friday, May 2nd. BTIG Research set a $403.00 price objective on shares of Stryker and gave the stock a "buy" rating in a research note on Monday, April 14th. Truist Financial increased their price objective on shares of Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research note on Monday, May 5th. Finally, Roth Mkm increased their price objective on shares of Stryker from $405.00 to $456.00 and gave the stock a "buy" rating in a research note on Friday, May 2nd. Four investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $427.30.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the sale, the director now directly owns 3,417,326 shares in the company, valued at $1,288,195,208.96. This trade represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 5.90% of the company's stock.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.